To the articles

USP Reference Standards – Standards of the United States Pharmacopeia
USP reference standards are the global quality benchmark for the analytical validation of pharmaceuticals, biologics, and excipients. Manufacturers of APIs, generics, complex biologics, or pharmaceutical raw materials require comparator substances that regulatory authorities and international pharmacopoeias fully trust.
As an authorized USP specialist retailer, we exclusively deliver standards – with the highest product safety, reliable supply chains and valid results for maximum patient safety.
The range of USP reference standards
Our portfolio includes thousands of USP standards , including:
✔ Drug active ingredient standards (APIs)
✔ Excipient standards
✔ Impurities & Degradation Products
✔ Nitrosamine standards
✔ Pharmaceutical Analytical Impurities (PAI)
✔ Analytical Reference Materials (ARM)
✔ Biologics Standards
✔ Compendial reagents
✔ Dissolution Performance Verification Standards (DPVS)
USP Pharmaceutical Analytical Impurities
READ MOREUSP Biologics
READ MOREUSP Analytical Reference Materials
READ MORE| Order no. | Article name | Batch number | CAS Number | Unit Price € | Quantity |
|---|---|---|---|---|---|
|
USP-1162545
Sale price1.059,78 €
|
Dalfampridine Related Compound A (25 mg) (4-Aminopyridine 1-oxide) |
3535-75-9 | 1.059,78 € | ||
|
USP-1162556
Sale price981,49 €
|
Dalfampridine Related Compound B (50 mg) (3,5-Dibromopyridine-4-amine) |
F053J0 | 84539-34-4 | 981,49 € | |
|
USP-1162567
Sale price981,49 €
|
Dalfampridine Related Compound C (25 mg) (1,3-Di(pyridin-4-yl)urea) |
R223D0 | 39642-87-0 | 981,49 € | |
|
USP-1163162
Sale price1.120,54 €
|
Dantrolene Related Compound A (50 mg) (1,2-Bis{[5-(4-nitrophenyl)furan-2-yl]methylene}hydrazine) |
R051J1 | 301359-05-7 | 1.120,54 € | |
|
USP-1163173
Sale price1.107,68 €
|
Dantrolene Related Compound B (50 mg) (5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl) semicarbazone) |
R222B0 | 57268-33-4 | 1.107,68 € | |
|
USP-1163184
Sale price1.099,50 €
|
Dantrolene Related Compound C (50 mg) (5-(4-Nitrophenyl)furan-2-carbaldehyde) |
R15680 | 7147-77-5 | 1.099,50 € | |
|
USP-1163264
Sale price1.070,29 €
|
Dapagliflozin Related Compound A (15 mg) ((2S,3R,4R,5S,6R)-2-[4-Bromo-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol) |
R251H0 | 1807632-95-6 | 1.070,29 € | |
|
USP-1164211
Sale price539,82 €
|
Darifenacin Chiral Peak ID Mixture (25 mg) (See USP Certificate for full Chemical Name) |
F04970 | N/A | 539,82 € | |
|
USP-1164222
Sale price508,27 €
|
Darifenacin Peak ID Mixture (25 mg) (A mixture consisting of Darifenacin Hydrobromide (99%), Dealkyl darifenacin (0.3%), Ketodarifenacin (0.2%), and 7-Bromo darifenacin (0.3%)) |
F04980 | N/A | 508,27 € | |
|
USP-1164233
Sale price969,81 €
|
Darifenacin Related Compound G (25 mg) (5-(2-Bromoethyl)-2,3-dihydrobenzofuran) |
F187T0 | 127264-14-6 | 969,81 € | |
|
USP-1164697
Sale price1.008,37 €
|
Daunorubicinone (25 mg) ((8S,10S)-8-acetyl-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione) |
R262F0 | 21794-55-8 | 1.008,37 € | |
